EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimising screening intervals and BI-RADS management pathways in ultrasound-based breast cancer screening: real-world evidence from Shenzhen (2018–2023)

Wanyi Sun, Huan Li, Xuelian Zhao, Shangying Hu, Haifeng Qi, Shuyan Jin, Wenxia Zhang, Fanghui Zhao

Breast Cancer Research and Treatment · 2026

DOI: 10.1007/s10549-026-08045-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2026. Verfasst von Wanyi Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sc…. Hauptthemen laut MEDLINE: Breast Neoplasms, Early Detection of Cancer, Ultrasonography, Mammary. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To identify screening intervals and BI-RADS–specific management pathways that balance cancer detection yield against recall burden in ultrasound-based breast cancer screening in China.

Methods

We analysed 1,694,838 ultrasound examinations reported with BI-RADS (2018–2023). For BI-RADS 1/2, inter-screen intervals were evaluated by recall rate, cancer detection rate (CDR), positive predictive value (PPV), and early-stage proportion. For BI-RADS 0/3/4/5, we assessed associations between biopsy waiting time and PPV/early-stage proportion, and examined imaging follow-up outcomes for BI-RADS 4A.

Results

Among 337,497 screening intervals following BI-RADS 1/2, longer intervals were associated with higher CDR (0.13–0.54 per 1,000) but higher recall (17.4%–22.1%) and lower PPV (61.1%–31.0%), while early-stage proportion remained stable. The interval that best balanced yield and downstream burden was 13–24 months for women aged ≥ 40 years and 25–36 months for women aged < 40 years, achieving higher detection yield and PPV without a material increase in recall. Among 1,949 BI-RADS 4/5 biopsies, PPV was low for 4A (12.3%–25.0%), declined markedly with biopsy delay for 4B (60.5% to 25.0%), and remained consistently high for 4C/5 (> 60%/>93%). Among BI-RADS 4A lesions 64.7% (10,909/16,871) showed imaging downgrading during follow-up. In 487 BI-RADS 3 cases undergoing biopsy, delayed biopsy increased PPV without changing early-stage proportion.

Conclusion

A 2-year screening interval is recommended for women aged 40–64 years, extendable to 3 years for those aged < 40. Prompt biopsy is warranted for BI-RADS 4B/4C/5. The high image downgrade rate of BI-RADS 4A suggests overestimation and supports imaging-based triage, requiring further validation. Imaging surveillance is preferable for BI-RADS 3 lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsEarly Detection of CancerUltrasonography, MammaryHumansFemaleMiddle AgedChinaAdultAgedMass Screening

Stichwörter der Autor:innen

BI-RADSBiopsy timingBreast cancer screeningClinical management pathwayReal-world evidenceScreening intervalUltrasound

Autor:innen und Institutionen

  • Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China.
  • Department of Breast Surgery, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
  • Department of Health Care Services, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
  • Department of Breast Surgery, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, Guangdong Province, China. zhangwenxia74@163.com.
  • Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China. zhaofan…

Zitieren

APA

Sun, W., Li, H., Zhao, X., Hu, S., Qi, H., Jin, S., Zhang, W., & Zhao, F. (2026). Optimising screening intervals and BI-RADS management pathways in ultrasound-based breast cancer screening: real-world evidence from Shenzhen (2018–2023). Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-026-08045-w

Vancouver

Sun W, Li H, Zhao X, Hu S, Qi H, Jin S, et al. Optimising screening intervals and BI-RADS management pathways in ultrasound-based breast cancer screening: real-world evidence from Shenzhen (2018–2023). Breast Cancer Research and Treatment. 2026. doi:10.1007/s10549-026-08045-w

BibTeX
@article{Sun2026,
  author = {Sun, Wanyi and Li, Huan and Zhao, Xuelian and Hu, Shangying and Qi, Haifeng and Jin, Shuyan and Zhang, Wenxia and Zhao, Fanghui},
  title = {Optimising screening intervals and BI-RADS management pathways in ultrasound-based breast cancer screening: real-world evidence from Shenzhen (2018–2023)},
  journal = {Breast Cancer Research and Treatment},
  year = {2026},
  doi = {10.1007/s10549-026-08045-w}
}
Kostenlos starten →